NCT06940843

Brief Summary

The goal of this clinical trial is to learn if a novel psychosocial intervention is effective in helping adults over 50 with serious mental illness (SMI) increase their social connections and participate in more healthy lifestyle activities. The Hopeful and Healthy Living (HHL) intervention combines social skills training and training in cognitive self-management strategies in order to help older adults build healthy lifestyle and social routines. We predict that:

  • Individuals who participate in the HHL intervention will improve more in perceived social support (i.e., what people get from relationships such as reliance, reassurance of worth, attachment) and loneliness at the 4-, 8-, and 12-month follow-up assessments than those who receive treatment as usual (TAU).
  • Individuals who participate in the HHL intervention will improve more in overall psychosocial functioning at the 4-, 8-, and 12-month follow-up assessments than those who receive TAU.
  • Individuals who participate in the HHL intervention will improve more in cognitive functioning at the 4-, 8-, and 12-month follow-up assessments than those who receive TAU.
  • Individuals who participate in the HHL intervention will improve more in healthy behaviors (sleep, activity, diet) at the 4-, 8-, and 12-month follow-up assessments than those who receive TAU. In this trial, participants will be either receive the HHL intervention or participate in their regular treatment activities (treatment as usual). HHL vs. TAU will be compared to see if there are any differences in social support, cognition, loneliness, psychosocial functioning, or healthy lifestyle activities including physical activity, sleep, and diet. Participants will be asked to complete an interview-based assessment at baseline, 4-months, 8-months, and 12-months. After completing the baseline assessment, those who are in the experimental group will participate in the 16-week long HHL group intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
27mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Mar 2025Jul 2028

Study Start

First participant enrolled

March 12, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 16, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

3.4 years

First QC Date

April 16, 2025

Last Update Submit

April 23, 2025

Conditions

Keywords

psychosocial interventionscognitive interventionssocial skills interventionshealthy lifestyle interventionsolder adults with SMI

Outcome Measures

Primary Outcomes (8)

  • Montreal Cognitive Assessment (MOCA)

    Standardized screening tool used for assessing cognition.

    Baseline, 4-, 8-, 12- month followup

  • The Cognitive Self-Efficacy Scale

    10-item measure that assesses confidence in everyday cognitive tasks.

    Baseline, 4-, 8-, 12- month followup

  • The DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure

    Adult will be used to assess and statistically control for mental health symptom severity.

    Baseline, 4-, 8-, 12- month followup

  • The UCLA Loneliness Scale-3-item instrument

    3-item screening tool for loneliness.

    Baseline, 4-, 8-, 12- month followup

  • The Social Provisions Scale

    24-item instrument that will be used to measure various types of social supports.

    Baseline, 4-, 8-, 12- month followup

  • The Physical Activity Scale for the Elderly (PASE)

    Standardized measurement of physical activity related to exercise, work, recreation, and daily living activities.

    Baseline, 4-, 8-, 12- month followup

  • Starting the Conversation

    A brief standardized survey for assessing daily eating habits.

    Baseline, 4-, 8-, 12- month followup

  • Pittsburg Sleep Quality Index (PSQI)

    An 11-item tool that is used to assess sleep quality and routines.

    Baseline, 4-, 8-, 12- month followup

Secondary Outcomes (1)

  • HHL Group Satisfaction and Feedback Survey

    4-month assessment only

Study Arms (2)

HHL group participants

EXPERIMENTAL

Participants will complete the 16-week manualized HHL intervention. This group intervention will occur weekly for 90 minutes. These participants will also continue with treatment as usual.

Behavioral: Hopeful and Healthy Living (HHL)

Treatment as usual

NO INTERVENTION

Participants assigned to this arm will continue with treatment as usual.

Interventions

The HHL intervention is a 16-week long, manualized group intervention. Classes will be held weekly for 90 minutes. The class covers 15 topics centered on building social connections, developing healthy lifestyle routines around eating, exercise, and sleep. Each class will target one social skill (i.e. starting conversations) and one cognitive self-management strategy (i.e. memory tips), which will be taught and practiced in class. Each class also includes a facilitated exercise component and individually tailored take home application activity.

HHL group participants

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older, diagnosis of a serious mental illness, and a member of Center Club or Transitions of Boston

You may not qualify if:

  • Diagnosis of dementia or other progressive neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bay Cove Center Club

Boston, Massachusetts, 02114, United States

RECRUITING

Bay Cove Transitions of Boston

Boston, Massachusetts, 02122, United States

RECRUITING

Study Officials

  • Susan McGurk, PhD

    Boston University

    PRINCIPAL INVESTIGATOR
  • Kim Mueser, PhD

    Boston University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alexa R Trolley-Hanson, MS OTR/L

CONTACT

Susan McGurk, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2025

First Posted

April 23, 2025

Study Start

March 12, 2025

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

July 31, 2028

Last Updated

April 25, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations